Overview
Thermo Fisher Scientific engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings.... Show more
Segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; Laboratory Products and Services
Rating: Strong Buy
Symbol: TMO
Exchange: NYSE
Sector: Healthcare
$188.49B

Market cap

Thermo Fisher Scientific Financial Health

Operating Efficiency:8.71/10

✅ Thermo Fisher Scientific has better Operating Efficiency than 90% of the companies on the Medical Diagnostics & Research industry

Operating Margin: 25.25%

✅ Thermo Fisher Scientific has better Operating Margin than 90% of the companies on the Medical Diagnostics & Research industry

Liquidity:8.35/10

✅ Thermo Fisher Scientific has better Liquidity than 80% of the companies on the Medical Diagnostics & Research industry

Quick Ratio: 2.31

✅ Thermo Fisher Scientific has better Quick Ratio than 60% of the companies on the Medical Diagnostics & Research industry

Operating Cash Flow Ratio: 1.1

✅ Thermo Fisher Scientific has better Operating Cash Flow Ratio than 80% of the companies on the Medical Diagnostics & Research industry

Solvency:5.69/10

❌ Thermo Fisher Scientific has worst Solvency than 50% of the companies on the Medical Diagnostics & Research industry

Debt to Equity Ratio: 0.66

✅ Thermo Fisher Scientific has better Debt to Equity Ratio than 70% of the companies on the Medical Diagnostics & Research industry

Interest Coverage Ratio: 1.1

✅ Thermo Fisher Scientific has better Interest Coverage Ratio than 80% of the companies on the Medical Diagnostics & Research industry

Thermo Fisher Scientific revenue quarter by quarter
Thermo Fisher Scientific operating expenses

👀 Get a summary of every week for free

Top company news, earnings report, analysis and more.

InspectCompany.com

We aim to help investors learn more about the companies in which they invest. We believe investing should be less about trying to find patterns in charts and more about investing in the companies that better represent your vision for the future.

Disclaimer: InspectCompany does not guarantee that any of the information available on our website, APIs or provided by any other means is complete, accurate, current, reliable or appropriate for your needs. Some of our information is provided by third party services and we cannot guarantee that is complete, accurate, current, reliable or appropriate for your needs. The information and recommendations on this site are for educational purposes only and should not be used to replace the advice of financial advisors and other professionals. All our services, information, data and/or recommendations are provided on an "as is" basis and without warranties of any kind, either express or implied. We do not guarantee that our services, information, data and/or recommendations are complete, accurate, current, reliable or appropriate for your needs.  Read more